Novel Protein-Based Therapeutics for Nerve Agent Detoxification
Novel Protein-Based Therapeutics for Nerve Agent Detoxification
批准号:
7634442
负责人:
Matthew R Redinbo
金额:
$50.38万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-27 至 2011-05-31
关键词:
AcetylcholinesteraseActive SitesAdverse effectsAgeAgingAmino AcidsAnimal ModelAnimalsArchitectureBindingBinding SitesBiochemicalBiological ModelsChemical WeaponsChemicalsCholinesterasesComplexDataDrug Metabolic DetoxicationEngineeringEnzymesExposure toGoalsHumanHuman ResourcesHydrolaseHydrolysisInvestigationLifeMedical ResearchMethodsMilitary PersonnelMolecularMusMutationNeurotransmittersNorth CarolinaOrganophosphatesPharmaceutical PreparationsProcessProteinsReactionResearch InstituteResearch PersonnelResistanceRiskSaint Jude Children&aposs Research HospitalSarinSerine HydrolaseSerumSiteSomanStructureSurfaceTestingTherapeuticToxic effectUniversitiesanalogbasebioscavengercatalystcyclosarindesigndrug metabolismemergency service responderesterasehuman carboxylesterase 1improvedin vitro activityin vivomethylphosphonatemutantnerve agentnovelprogramsprophylactictabun
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The organophosphate nerve agents tabun (GA), sarin (GB), soman (GD), cyclosarin (GF), VX, and Russian VX (R-VX) are among the deadliest compounds known. Current treatments for chemical weapons exposure offer limited protection, must be administered immediately, and can generate long-term toxic side effects. Human carboxylesterase 1 (hCE1), a promiscuous drug metabolism enzyme, offers promise as a broad- spectrum protein-based therapeutic for nerve agent detoxification. We have determined several crystal structures of hCE1 in complex with live nerve agents. These preliminary results have indicated that the enzyme is both stereoselective and resistant to aging, and provides two putative nerve agent binding sites: the active site and a promiscuous surface binding site. The focus of this application is to convert hCE1 into a highly efficient nerve agent hydrolase using a range of targeted structural, biochemical and in vivo studies. A team of investigators at the University of North Carolina at Chapel Hill, St. Jude Children's Research Hospital, and the US Army Medical Research Institute of Chemical Defense has been assembled, and four specific aims will be pursued: 1. Elucidate crystal structures of hCE1 in complex with a wide variety of live nerve agents. 2. Introduce targeted mutations designed to improve nerve agent binding and hydrolysis. 3. Examine the impact site-directed mutants have on hCETs nerve agent hydrolysis activity in vitro. 4. Assess the in vivo ability of engineered forms of hCE1 to protect serum esterase-deficient mice from exposure to nerve agents. The overall goal of these on-going investigations is to develop a novel, efficient, broad-spectrum protein- based therapeutic for prophylactic protection against nerve agent exposure. It is clear that effective catalytic countermeasures are urgently needed to safely protect military personnel and civilian first-responders from attacks involving chemical weapons.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding and Controlling Drug Metabolism by the Gut Microbiota to Improve Human Health
-
批准号:10401799
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2020
-
负责人:Matthew R Redinbo
-
依托单位:
Understanding and Controlling Drug Metabolism by the Gut Microbiota to Improve Human Health
-
批准号:10616518
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2020
-
负责人:Matthew R Redinbo
-
依托单位:
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes
-
批准号:10438768
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2019
-
负责人:Matthew R Redinbo
-
依托单位:
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes
-
批准号:10205109
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2019
-
负责人:Matthew R Redinbo
-
依托单位:
Structural Basis for Hormone and Neurotransmitter Processing by Gut Microbial Enzymes
-
批准号:10019410
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2019
-
负责人:Matthew R Redinbo
-
依托单位:
Improving CPT-11 Efficacy Using Structural and Chemical Biology
-
批准号:8817985
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2014
-
负责人:Matthew R Redinbo
-
依托单位:
Improving CPT-11 Efficacy Using Structural and Chemical Biology
-
批准号:9326146
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2014
-
负责人:Matthew R Redinbo
-
依托单位:
Improving CPT-11 Efficacy Using Structural and Chemical Biology
-
批准号:8931901
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2014
-
负责人:Matthew R Redinbo
-
依托单位:
Improving CPT-11 Efficacy Using Structural and Chemical Biology
-
批准号:9128581
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2014
-
负责人:Matthew R Redinbo
-
依托单位:
Structural Biology Core Facility
-
批准号:8340313
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2011
-
负责人:Matthew R Redinbo
-
依托单位:
STRUCTURAL STUDIES OF THERAPEUTIC DRUG TARGETS
-
批准号:7954336
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2009
-
负责人:Matthew R Redinbo
-
依托单位:
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
-
批准号:7620972
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2008
-
负责人:Matthew R Redinbo
-
依托单位:
STRUCTURAL STUDIES OF THERAPEUTIC DRUG TARGETS
-
批准号:7721988
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:Matthew R Redinbo
-
依托单位:
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
-
批准号:7912092
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2008
-
负责人:Matthew R Redinbo
-
依托单位:
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
-
批准号:7866607
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2008
-
负责人:Matthew R Redinbo
-
依托单位:
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
-
批准号:8274770
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2008
-
负责人:Matthew R Redinbo
-
依托单位:
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
-
批准号:7503206
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2008
-
负责人:Matthew R Redinbo
-
依托单位:
Structure and Inhibition of the Conjugative DNA Relaxase-Helicase
-
批准号:8075414
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2008
-
负责人:Matthew R Redinbo
-
依托单位:
STRUCTURAL STUDIES OF THERAPEUTIC DRUG TARGETS
-
批准号:7598243
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2007
-
负责人:Matthew R Redinbo
-
依托单位:
STRUCTURAL STUDIES OF HUMAN TOPOISOMERASE I AND DRUG PROCESSING ESTERASES
-
批准号:7597887
-
项目类别:
-
资助金额:$0.28万
-
财政年份:2007
-
负责人:Matthew R Redinbo
-
依托单位:
海外基金